Relmada Therapeutics, Inc (RLMD) insider trading
Every open-market stock purchase and sale by Relmada Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $2.4M over the last 12 months (6 buys).
- Last insider buy: Sergio Traversa (CEO), $113K, 10 months ago.
Last 12 months: insiders bought $2.4M (6 buys) and sold $0 (0 sales). Last close $5.72 on Jun 7, 2026.
Recent RLMD insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Dec 15, 2025 | Sergio Traversa (CEO) | Bought | $113K |
| Dec 15, 2025 | Maged Shenouda (CFO) | Bought | $48.1K |
| Dec 12, 2025 | Chuck Ence (Officer) | Bought (not open market) | — |
| Dec 12, 2025 | Charles J Casamento (Director) | Bought (not open market) | — |
| Dec 12, 2025 | John Glasspool (Director) | Bought (not open market) | — |
| Dec 12, 2025 | Fabiana Fedeli (Director) | Bought (not open market) | — |
| Dec 12, 2025 | Maged Shenouda (CFO) | Bought (not open market) | — |
| Dec 12, 2025 | Paul Edward Kelly (COO) | Bought (not open market) | — |
| Dec 12, 2025 | Sergio Traversa (CEO) | Bought (not open market) | — |
| Nov 5, 2025 | Maged Shenouda (CFO) | Bought | $1.1M |
| Nov 5, 2025 | Sergio Traversa (CEO) | Bought | $600K |
| Nov 5, 2025 | Chuck Ence (COO) | Bought | $299K |
| Nov 5, 2025 | Paul Edward Kelly (COO) | Bought | $198K |
Who's trading RLMD
- Maged Shenouda, CFO: bought $1.1M (2 buys), last Dec 15, 2025
- Sergio Traversa, CEO: bought $713K (2 buys), last Dec 15, 2025
- Fabiana Fedeli, Director: other filings, last Dec 12, 2025
- Charles J Casamento, Director: other filings, last Dec 12, 2025
- Paul Edward Kelly, Director: bought $198K (1 buy), last Dec 12, 2025
- John Glasspool, Director: other filings, last Dec 12, 2025
- Chuck Ence, Officer: bought $299K (1 buy), last Dec 12, 2025
Get free alerts when an insider at Relmada Therapeutics, Inc files a new trade →